These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 19036881)
1. Role of c-Myb during prolactin-induced signal transducer and activator of transcription 5a signaling in breast cancer cells. Fang F; Rycyzyn MA; Clevenger CV Endocrinology; 2009 Apr; 150(4):1597-606. PubMed ID: 19036881 [TBL] [Abstract][Full Text] [Related]
2. The transcriptional responsiveness of LKB1 to STAT-mediated signaling is differentially modulated by prolactin in human breast cancer cells. Linher-Melville K; Singh G BMC Cancer; 2014 Jun; 14():415. PubMed ID: 24913037 [TBL] [Abstract][Full Text] [Related]
3. STAT5 and prolactin participate in a positive autocrine feedback loop that promotes angiogenesis. Yang X; Meyer K; Friedl A J Biol Chem; 2013 Jul; 288(29):21184-21196. PubMed ID: 23729680 [TBL] [Abstract][Full Text] [Related]
4. Prolactin inhibits BCL6 expression in breast cancer through a Stat5a-dependent mechanism. Tran TH; Utama FE; Lin J; Yang N; Sjolund AB; Ryder A; Johnson KJ; Neilson LM; Liu C; Brill KL; Rosenberg AL; Witkiewicz AK; Rui H Cancer Res; 2010 Feb; 70(4):1711-21. PubMed ID: 20124477 [TBL] [Abstract][Full Text] [Related]
5. Coactivation of janus tyrosine kinase (Jak)1 positively modulates prolactin-Jak2 signaling in breast cancer: recruitment of ERK and signal transducer and activator of transcription (Stat)3 and enhancement of Akt and Stat5a/b pathways. Neilson LM; Zhu J; Xie J; Malabarba MG; Sakamoto K; Wagner KU; Kirken RA; Rui H Mol Endocrinol; 2007 Sep; 21(9):2218-32. PubMed ID: 17550976 [TBL] [Abstract][Full Text] [Related]
6. Autocrine prolactin promotes prostate cancer cell growth via Janus kinase-2-signal transducer and activator of transcription-5a/b signaling pathway. Dagvadorj A; Collins S; Jomain JB; Abdulghani J; Karras J; Zellweger T; Li H; Nurmi M; Alanen K; Mirtti T; Visakorpi T; Bubendorf L; Goffin V; Nevalainen MT Endocrinology; 2007 Jul; 148(7):3089-101. PubMed ID: 17412813 [TBL] [Abstract][Full Text] [Related]
7. Quantification of PRL/Stat5 signaling with a novel pGL4-CISH reporter. Fang F; Antico G; Zheng J; Clevenger CV BMC Biotechnol; 2008 Feb; 8():11. PubMed ID: 18254957 [TBL] [Abstract][Full Text] [Related]
8. Prolactin induces up-regulation of its cognate receptor in breast cancer cells via transcriptional activation of its generic promoter by cross-talk between ERĪ± and STAT5. Kavarthapu R; Tsai Morris CH; Dufau ML Oncotarget; 2014 Oct; 5(19):9079-91. PubMed ID: 25193864 [TBL] [Abstract][Full Text] [Related]
10. Co-overexpression of Janus kinase 2 and signal transducer and activator of transcription 5a promotes differentiation of mammary cancer cells through reversal of epithelial-mesenchymal transition. Sultan AS; Brim H; Sherif ZA Cancer Sci; 2008 Feb; 99(2):272-9. PubMed ID: 18271926 [TBL] [Abstract][Full Text] [Related]
11. Synergistic action of prolactin (PRL) and androgen on PRL-inducible protein gene expression in human breast cancer cells: a unique model for functional cooperation between signal transducer and activator of transcription-5 and androgen receptor. Carsol JL; Gingras S; Simard J Mol Endocrinol; 2002 Jul; 16(7):1696-710. PubMed ID: 12089361 [TBL] [Abstract][Full Text] [Related]
12. Induction of multidrug resistance transporter ABCG2 by prolactin in human breast cancer cells. Wu AM; Dalvi P; Lu X; Yang M; Riddick DS; Matthews J; Clevenger CV; Ross DD; Harper PA; Ito S Mol Pharmacol; 2013 Feb; 83(2):377-88. PubMed ID: 23150485 [TBL] [Abstract][Full Text] [Related]
13. Prolactin induces SHP-2 association with Stat5, nuclear translocation, and binding to the beta-casein gene promoter in mammary cells. Chughtai N; Schimchowitsch S; Lebrun JJ; Ali S J Biol Chem; 2002 Aug; 277(34):31107-14. PubMed ID: 12060651 [TBL] [Abstract][Full Text] [Related]
14. SOCS3 as a tumor suppressor in breast cancer cells, and its regulation by PRL. Barclay JL; Anderson ST; Waters MJ; Curlewis JD Int J Cancer; 2009 Apr; 124(8):1756-66. PubMed ID: 19115200 [TBL] [Abstract][Full Text] [Related]
15. Prolactin Signaling Stimulates Invasion via Na(+)/H(+) Exchanger NHE1 in T47D Human Breast Cancer Cells. Pedraz-Cuesta E; Fredsted J; Jensen HH; Bornebusch A; Nejsum LN; Kragelund BB; Pedersen SF Mol Endocrinol; 2016 Jul; 30(7):693-708. PubMed ID: 27176613 [TBL] [Abstract][Full Text] [Related]
16. The role of prolactin receptor in GH signaling in breast cancer cells. Xu J; Sun D; Jiang J; Deng L; Zhang Y; Yu H; Bahl D; Langenheim JF; Chen WY; Fuchs SY; Frank SJ Mol Endocrinol; 2013 Feb; 27(2):266-79. PubMed ID: 23192981 [TBL] [Abstract][Full Text] [Related]
17. Histone H1 and Chromosomal Protein HMGN2 Regulate Prolactin-induced STAT5 Transcription Factor Recruitment and Function in Breast Cancer Cells. Schauwecker SM; Kim JJ; Licht JD; Clevenger CV J Biol Chem; 2017 Feb; 292(6):2237-2254. PubMed ID: 28035005 [TBL] [Abstract][Full Text] [Related]
18. Stat5 activation inhibits prolactin-induced AP-1 activity: distinct prolactin-initiated signals in tumorigenesis dependent on cell context. Gutzman JH; Rugowski DE; Nikolai SE; Schuler LA Oncogene; 2007 Sep; 26(43):6341-8. PubMed ID: 17438530 [TBL] [Abstract][Full Text] [Related]
19. Transcriptional inhibition by Stat5. Differential activities at growth-related versus differentiation-specific promoters. Luo G; Yu-Lee L J Biol Chem; 1997 Oct; 272(43):26841-9. PubMed ID: 9341115 [TBL] [Abstract][Full Text] [Related]
20. Mucuna pruriens (L.) DC chemo sensitize human breast cancer cells via downregulation of prolactin-mediated JAK2/STAT5A signaling. Sinha S; Sharma S; Vora J; Shah H; Srivastava A; Shrivastava N J Ethnopharmacol; 2018 May; 217():23-35. PubMed ID: 29427634 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]